Investigation of the Role of the Microbiome in the Pathogenesis of Colorectal Adenoma and Carcinoma
NCT ID: NCT02947607
Last Updated: 2023-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
799 participants
OBSERVATIONAL
2016-07-31
2019-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Human Intestinal Microbiome and Surgical Outcomes in Patients Undergoing Colorectal Cancer Surgery
NCT04005118
Microbiome and Colorectal Cancer Recurrence
NCT07057076
Microbiome in Colorectal Cancer Onset and Progression
NCT05368688
Early Detection of Treatment Failure in Metastatic Colorectal Cancer Patients
NCT05068531
Relapse Markers for Colorectal Cancer
NCT04920955
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy control
Patients undergoing lower GI endoscopy without any colorectal adenoma or carcinoma.
Colon biopsies
Adenoma
Patients undergoing lower GI endoscopy with presence of colorectal adenoma detected.
Colon biopsies
Colorectal cancer
Patients diagnosed with colorectal cancer and referred to surgical carcinoma resection.
Colon biopsies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Colon biopsies
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or female, aged 18 years or above
* Referred to lower GI endoscopy. Referral reasons can be among others:
* Positive FOBT (Fecal Occult Blood Test)
* Follow up after polypectomy
* Screening because of age
* Bleeding
* Abdominal pain
* Familial or past history of colon cancer or adenoma
* Abnormal imaging such as barium enema
* Change in bowel habits
* Both self-referrals, referrals from external GP or specialists and internal referrals can be included.
* Participant is willing and able to give informed consent for the participation in the study before any protocol-specific screening procedures are performed
* Male or female, aged 18 years or above
* Diagnosis of CRC for which resection is planned
* Both internal and external referrals from specialists can be included
Exclusion Criteria
* Previous diagnosis of intestinal polyposis syndrome
CRC patients
* Previous diagnosis of an inflammatory bowel disease
* Previous diagnosis of intestinal polyposis syndrome
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Janssen Pharmaceutica N.V., Belgium
INDUSTRY
KU Leuven
OTHER
Universitaire Ziekenhuizen KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitaire Ziekenhuizen Leuven
Leuven, Flemish Brabant, Belgium
Academisch Medisch Centrum
Amsterdam, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
s57084
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.